-
March 13, 2018
9:00 pm UTC
VolitionRx Announces Closing of $8.4 Million Public Offering of Common Stock
-
March 09, 2018
3:00 pm UTC
VolitionRx Announces Pricing of $8.4 Million Public Offering of Common Stock
-
March 08, 2018
10:00 pm UTC
VolitionRx Announces Proposed Underwritten Public Offering of Common Stock
-
March 07, 2018
2:00 pm UTC
VolitionRx Appoints Harvard Professor, Dr. Lee-Jen Wei to Its Scientific Advisory Board
-
March 01, 2018
10:00 pm UTC
VolitionRX Limited Announces Full Fiscal Year 2017 Financial Results and Business Update
-
February 28, 2018
10:00 pm UTC
VolitionRx Limited Schedules Full Year 2017 Earnings Conference Call and Business Update
-
February 26, 2018
10:00 pm UTC
VolitionRx Limited Announces Interim Results from 680-Subject Clinical Trial in Colorectal Cancer
-
February 05, 2018
2:00 pm UTC
VolitionRX Announces the Successful Conclusion of the Logistics and Pathway Design Study Conducted in Denmark.
-
January 03, 2018
2:00 pm UTC
VolitionRx Limited Releases Letter to Shareholders Including Status Update on Key Clinical Milestone